Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY17.87 CNY
Change Today +0.38 / 2.17%
Volume 19.0M
As of 3:05 AM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

mayinglong pharmaceutical-a (600993) Snapshot

Open
CNY16.70
Previous Close
CNY17.49
Day High
CNY18.40
Day Low
CNY16.25
52 Week High
06/3/15 - CNY40.40
52 Week Low
09/16/14 - CNY13.80
Market Cap
7.7B
Average Volume 10 Days
20.2M
EPS TTM
CNY0.50
Shares Outstanding
431.1M
EX-Date
07/21/15
P/E TM
36.0x
Dividend
CNY0.03
Dividend Yield
0.17%
Current Stock Chart for MAYINGLONG PHARMACEUTICAL-A (600993)

Related News

No related news articles were found.

mayinglong pharmaceutical-a (600993) Related Businessweek News

No Related Businessweek News Found

mayinglong pharmaceutical-a (600993) Details

Mayinglong Pharmaceutical Group Co., Ltd. engages in the manufacture, wholesale, and retail of pharmaceutical products primarily in China. It offers hemorrhoid, gynecological, cough, skin, and other products, as well as drugstore and merchants varieties. The company provides its products in various dosage forms comprising ointments, suppositories, tablets, pastes and granules, and oral solutions. It also produces and distributes eye cream products under the Mayinglong BaBao brand name, as well as operates hospitals. Mayinglong Pharmaceutical Group Co., Ltd. was founded in 1582 and is based in Wuhan, China.

Founded in 1582

mayinglong pharmaceutical-a (600993) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

mayinglong pharmaceutical-a (600993) Key Developments

Mayinglong Pharmaceutical Group Co,.Ltd Reports Earnings Results for the First Half of 2015

Mayinglong Pharmaceutical Group Co,.LTD reported earnings results for the first half of 2015. For the period, the company reported basic earnings per share to be CNY 0.43 and weighted average return on net assets of 8.74%.

Mayinglong Pharmaceutical Group Co,.LTD to Report First Half, 2015 Results on Aug 22, 2015

Mayinglong Pharmaceutical Group Co,.LTD announced that they will report first half, 2015 results on Aug 22, 2015

Mayinglong Pharmaceutical Group Co,.LTD Announces Profit Distribution Payable on July 21, 2015

Mayinglong Pharmaceutical Group Co,.LTD announced profit distribution of RMB 0.40 tax included and 3 bonus shares for every 10 shares payable on July 21, 2015 to the shareholders of record as on July 20, 2015. The ex-dividend date is July 21, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600993:CH CNY17.87 CNY +0.38

600993 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600993.
View Industry Companies
 

Industry Analysis

600993

Industry Average

Valuation 600993 Industry Range
Price/Earnings 34.8x
Price/Sales 4.6x
Price/Book 4.4x
Price/Cash Flow 35.0x
TEV/Sales 3.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MAYINGLONG PHARMACEUTICAL-A, please visit www.mayinglong.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.